Audrey Gabelle

10.2k total citations
145 papers, 3.6k citations indexed

About

Audrey Gabelle is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Audrey Gabelle has authored 145 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Physiology, 73 papers in Psychiatry and Mental health and 32 papers in Molecular Biology. Recurrent topics in Audrey Gabelle's work include Dementia and Cognitive Impairment Research (68 papers), Alzheimer's disease research and treatments (67 papers) and Advanced Proteomics Techniques and Applications (10 papers). Audrey Gabelle is often cited by papers focused on Dementia and Cognitive Impairment Research (68 papers), Alzheimer's disease research and treatments (67 papers) and Advanced Proteomics Techniques and Applications (10 papers). Audrey Gabelle collaborates with scholars based in France, United States and Spain. Audrey Gabelle's co-authors include Sylvain Lehmann, Christophe Hirtz, Jérôme Vialaret, Claudine Berr, Susanna Schraen‐Maschke, Jacques Touchon, Nicolas R. Barthélemy, Constance Delaby, Yves Dauvilliers and Claire Paquet and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Audrey Gabelle

143 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Audrey Gabelle France	35	1.6k	1.1k	1.0k	570	502	145	3.6k
Claire Paquet France	34	1.8k 1.2×	1.0k 0.9×	1.0k 1.0×	686 1.2×	379 0.8×	177	4.4k
Julius Popp Switzerland	36	1.5k 0.9×	1.0k 0.9×	946 0.9×	297 0.5×	451 0.9×	112	4.2k
Lei Yu United States	33	1.9k 1.2×	1.4k 1.3×	934 0.9×	763 1.3×	409 0.8×	94	4.0k
Cláudia Kimie Suemoto Brazil	35	1.6k 1.0×	1.2k 1.1×	739 0.7×	462 0.8×	567 1.1×	258	4.7k
Alan J. Lerner United States	31	1.1k 0.7×	1.1k 1.0×	1.3k 1.3×	504 0.9×	505 1.0×	135	4.3k
Elizabeth Pirraglia United States	32	2.0k 1.3×	1.3k 1.2×	707 0.7×	408 0.7×	545 1.1×	62	3.7k
Chen‐Chen Tan China	31	1.6k 1.0×	1.4k 1.3×	1.0k 1.0×	380 0.7×	414 0.8×	115	4.6k
Lin Tan China	31	1.6k 1.0×	1.2k 1.1×	1.5k 1.5×	334 0.6×	375 0.7×	85	4.6k
Ging‐Yuek Robin Hsiung Canada	31	1.5k 1.0×	1.2k 1.1×	591 0.6×	1.1k 1.9×	373 0.7×	167	3.9k
Ana Frank Spain	34	1.9k 1.2×	1.2k 1.1×	956 0.9×	413 0.7×	632 1.3×	100	4.4k

Countries citing papers authored by Audrey Gabelle

Since Specialization

Citations

This map shows the geographic impact of Audrey Gabelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Gabelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Gabelle more than expected).

Fields of papers citing papers by Audrey Gabelle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Gabelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Gabelle. The network helps show where Audrey Gabelle may publish in the future.

Co-authorship network of co-authors of Audrey Gabelle

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Gabelle. A scholar is included among the top collaborators of Audrey Gabelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Gabelle. Audrey Gabelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Busto, Germain U., Christophe Hirtz, Isabelle Carrière, et al.. (2025). A six-year risk assessment for dementia and Alzheimer's disease in the general population through immunoprecipitation-mass spectrometry plasma amyloid quantification. The Journal of Prevention of Alzheimer s Disease. 12(7). 100186–100186.

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2024). Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment. Journal of Neurology Neurosurgery & Psychiatry. 95(11). 1046–1053. 20 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Luc Buée, et al.. (2024). Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease. Molecular Neurodegeneration. 19(1). 66–66. 8 indexed citations

Blum, David, Hélène Behal, Jean‐Sébastien Vidal, et al.. (2024). Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study. Alzheimer s & Dementia. 20(10). 6948–6959. 5 indexed citations

Lista, Simone, Mark Mapstone, Filippo Caraci, et al.. (2024). A critical appraisal of blood-based biomarkers for Alzheimer’s disease. Ageing Research Reviews. 96. 102290–102290. 16 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2023). Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum. International Journal of Molecular Sciences. 24(24). 17361–17361. 12 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2023). Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function. Journal of Neurology Neurosurgery & Psychiatry. 94(6). 411–419. 32 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2023). Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia. Clinical Chemistry. 69(9). 1072–1083. 4 indexed citations

Pang, Menglan, Audrey Gabelle, Paramita Saha‐Chaudhuri, et al.. (2023). Precision medicine analysis of heterogeneity in individual‐level treatment response to amyloid beta removal in early Alzheimer's disease. Alzheimer s & Dementia. 20(2). 1102–1111. 14 indexed citations

10.

Hirtz, Christophe, Germain U. Busto, Karim Bennys, et al.. (2023). Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer’s disease diagnosis in a memory clinic cohort. Alzheimer s Research & Therapy. 15(1). 34–34. 14 indexed citations

11.

Delaby, Constance, Daniel Alcolea, Christophe Hirtz, et al.. (2022). Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles. Journal of Neural Transmission. 129(2). 231–237. 16 indexed citations

12.

Cyprien, Fabienne, Claudine Berr, Jerome J. Maller, et al.. (2021). Late-life cynical hostility is associated with white matter alterations and the risk of Alzheimer's disease. Psychological Medicine. 52(15). 3636–3645. 6 indexed citations

13.

Leroy, Mélanie, Émilie Olié, Éloi Magnin, et al.. (2021). Characteristics of Bipolar Patients with Cognitive Impairment of Suspected Neurodegenerative Origin: A Multicenter Cohort. Journal of Personalized Medicine. 11(11). 1183–1183. 8 indexed citations

14.

Lehmann, Sylvain, Julien Dumurgier, Xavier Ayrignac, et al.. (2020). Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals. Alzheimer s Research & Therapy. 12(1). 123–123. 40 indexed citations

15.

Saracino, Dario, Vincent Huin, Fabienne Clot, et al.. (2020). Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations. Parkinsonism & Related Disorders. 80. 73–81. 11 indexed citations

16.

Lehmann, Sylvain, Constance Delaby, J. Touchon, Christophe Hirtz, & Audrey Gabelle. (2013). Biomarkers of Alzheimer's disease: The present and the future. Revue Neurologique. 169(10). 719–723. 16 indexed citations

17.

Mouton‐Liger, François, David Wallon, Anne‐Cécile Troussière, et al.. (2013). Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study. Journal of Neurology. 261(1). 144–151. 43 indexed citations

18.

Relaño-Ginés, Aroa, Audrey Gabelle, Claire Hamela, et al.. (2013). Prion Replication Occurs in Endogenous Adult Neural Stem Cells and Alters Their Neuronal Fate: Involvement of Endogenous Neural Stem Cells in Prion Diseases. PLoS Pathogens. 9(8). e1003485–e1003485. 25 indexed citations

19.

Vercelletto, Martine, Claire Boutoleau‐Bretonnière, Christelle Volteau, et al.. (2011). Memantine in Behavioral Variant Frontotemporal Dementia: Negative Results. Journal of Alzheimer s Disease. 23(4). 749–759. 75 indexed citations

20.

Gabelle, Audrey, Stéphane Roche, Christian Gény, et al.. (2010). Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid. Brain Research. 1357. 175–183. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact